Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Protein farnesyltransferase inhibitor from Banyu and Merck & Co.

May 31, 1996

Small-molecule alpha4 integrin antagonists generation disclosed by Biogen

May 31, 1996

Potential hypoxic marker synthesized by Evanston Hospital

May 31, 1996

PKC pathway activation may have therapeutic significance in bone disease management

May 31, 1996

OC104-26 identified as multidrug resistance (MDR)-reversing agent

May 31, 1996

ISIS-7597, an antisense oligonucleotide, shows promise in battling multidrug resistance

May 31, 1996

A highly lipophilic delta7-PGAI analogue, TEI-9826, demonstrates antitumor activity

May 31, 1996

Ligand reveals RXR-selective retinoid

May 31, 1996

MF-13 revealed as a selective tumor apoptosis-inducing agent

May 31, 1996

NSC-652287D shows important antitumor activity

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...